Indonesian Political, Business & Finance News

Video: Dony Oskario and Danantara's Efforts to Resolve State-Owned Pharmaceutical Company Problems

| Source: CNBC Indonesia Translated from Indonesian | Economy
Video: Dony Oskario and Danantara's Efforts to Resolve State-Owned Pharmaceutical Company Problems
Image: CNBC Indonesia

Chief Operating Officer of BPI Danantara and Head of the SOE Regulatory Body, Dony Oskaria, has stated that BPI Danantara is ensuring the streamlining process of state-owned enterprises is aimed at improving SOE performance, and therefore will not impact employees, including no layoffs.

Dony Oskaria said that efforts to resolve SOE problems will reduce losses and achieve savings of up to Rp 60 trillion, meaning that improvement efforts at Telkomsel and PT Pos will not involve any employee layoffs.

On the pharmaceutical SOE side, Danantara is carrying out transformation through a holding company under Bio Farma. One of the improvements has been made at Kimia Farma, which faced deep financial problems caused by unmeasured investment through the construction of large factories with low utilisation, as well as Kimia Farma Apotek, which operates 1,000 pharmacies with investment issues.

Danantara has carried out a fundamental transformation of Kimia Farma through management and business restructuring, enabling the company to be rescued and to record a profit. However, Indofarma is experiencing severe problems, with its subsidiary PT Indofarma Global Medika (IGM) undergoing bankruptcy proceedings.

More from 27 August 2026 โ†’

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/video-dony-oskario-and-danantaras-efforts-to-resolve-state-owned-pharmaceutical-company-problems-1787809874)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/news/20260827090726-8-762609/video-dony-oskario-putar-otak-danantara-atasi-masalah-bumn-farmasi), translated from Indonesian
Print